ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
This year saw more readjustments from the pandemic
The journalist and producer will begin his new role in February
The German major is reorienting its research toward cutting greenhouse gas emissions, lowering resource use, and supporting the circular economy
Analysts are split over whether the Inflation Reduction Act will be a boon for patients or a bust for the pharmaceutical industry
Mold, particulates, and inadequate ventilation in houses may explain why many Indigenous children have respiratory illnesses
Nearly a decade after Agilent stopped making the instruments, researchers work to keep old systems running
Ableist attitudes in STEM responsible for pay disparities, researcher says
Las barreras lingüísticas que frenan a los investigadores rara vez se contemplan en las conversaciones sobre diversidad en ciencia
The moments, numbers, and news that the C&EN team found noteworthy this year
In both Cambridge, Massachusetts, and Cambridge, England, the firm will hunt for new drug targets in the genetic diversity of individual cells
A single enzyme stereoselectively builds cyclic amides with 4-, 5-, and 6-membered rings
Researchers turn commercial plastic into reusable monomer without solvent or extreme temperatures
Device could improve studies of materials and living cells
Nearly a decade after Agilent stopped making the instruments, researchers work to keep old systems running